Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000007

See Remarks sold 6,430 shares at an average $68.36 ($439,566)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrow Jeffrey S See Remarks 2026-03-17 Sale −2,111 $69.42 $146,546 47,635 D
Farrow Jeffrey S See Remarks 2026-03-18 Sale −2,133 $68.71 $146,558 45,502 D
Farrow Jeffrey S See Remarks 2026-03-19 Sale −2,186 $67.00 $146,462 43,316 D
Open-market sales · 6,430 sh · avg $68.36 · $439,566
Loading xslF345X06/wk-form4_1773961430.xml…